<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23399503</PMID><DateCompleted><Year>2014</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1578-1275</ISSN><JournalIssue CitedMedium="Internet"><Volume>44 Suppl 1</Volume><Issue>Suppl 1</Issue><PubDate><Year>2012</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Atencion primaria</Title><ISOAbbreviation>Aten Primaria</ISOAbbreviation></Journal><ArticleTitle>[Preventive cardiovascular recommendations].</ArticleTitle><Pagination><StartPage>3</StartPage><EndPage>15</EndPage><MedlinePgn>3-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0212-6567(12)70010-0</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0212-6567(12)70010-0</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gal&#xe1;n</LastName><ForeName>Antonio Maiques</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Grupo de Prevenci&#xf3;n Cardiovascular del PAPPS.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuixart</LastName><ForeName>Carlos Brotons</ForeName><Initials>CB</Initials></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez</LastName><ForeName>Fernando Villar</ForeName><Initials>FV</Initials></Author><Author ValidYN="Y"><LastName>P&#xe9;rez</LastName><ForeName>Jorge Navarro</ForeName><Initials>JN</Initials></Author><Author ValidYN="Y"><LastName>Lobos-Bejarano</LastName><ForeName>Jos&#xe9; Mar&#xed;a</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Pinilla</LastName><ForeName>Ricardo Ortega</ForeName><Initials>RO</Initials></Author><Author ValidYN="Y"><LastName>Riobo&#xf3;</LastName><ForeName>Enrique Mart&#xed;n</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Banegas Banegas</LastName><ForeName>Jos&#xe9; Ram&#xf3;n</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Orozco-Beltr&#xe1;n</LastName><ForeName>Domingo</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Guill&#xe9;n</LastName><ForeName>Vicente Gil</ForeName><Initials>VG</Initials></Author><Author ValidYN="Y"><CollectiveName>Grupo de Prevenci&#xf3;n Cardiovascular del Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud</CollectiveName></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList><VernacularTitle>Recomendaciones preventivas cardiovasculares.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Aten Primaria</MedlineTA><NlmUniqueID>9111075</NlmUniqueID><ISSNLinking>0212-6567</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050171" MajorTopicYN="N">Dyslipidemias</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>2</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23399503</ArticleId><ArticleId IdType="pmc">PMC8171396</ArticleId><ArticleId IdType="doi">10.1016/S0212-6567(12)70010-0</ArticleId><ArticleId IdType="pii">S0212-6567(12)70010-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22980944</PMID><DateCompleted><Year>2013</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1275</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>12</Issue><PubDate><Year>2012</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Atencion primaria</Title><ISOAbbreviation>Aten Primaria</ISOAbbreviation></Journal><ArticleTitle>[Evidence-based anti-platelet treatment: PAPPS recommendations].</ArticleTitle><Pagination><StartPage>734</StartPage><EndPage>736</EndPage><MedlinePgn>734-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aprim.2012.07.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0212-6567(12)00345-9</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brotons Cuixart</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n, Equipo de Atenci&#xf3;n Primaria Sardenya-Instituto de Investigaci&#xf3;n Biom&#xe9;dica Sant Pau.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobos Bejarano</LastName><ForeName>Jos&#xe9; Mar&#xed;a</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Mart&#xed;n Riobo&#xf3;</LastName><ForeName>Enrique</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Gal&#xe1;n</LastName><ForeName>Antonio Maiques</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><CollectiveName>Grupo de Prevenci&#xf3;n Cardiovascular del Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud (PAPPS)</CollectiveName></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList><VernacularTitle>Evidencias del tratamiento antiagregante. Recomendaciones PAPPS.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2012</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Aten Primaria</MedlineTA><NlmUniqueID>9111075</NlmUniqueID><ISSNLinking>0212-6567</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22980944</ArticleId><ArticleId IdType="pmc">PMC7025623</ArticleId><ArticleId IdType="doi">10.1016/j.aprim.2012.07.004</ArticleId><ArticleId IdType="pii">S0212-6567(12)00345-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baigent C., Blackwell L., Collins R., Emberson J., Godwin J., Antithrombotic Trialists Collaboration (ATT) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849&#x2013;1860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2715005</ArticleId><ArticleId IdType="pubmed">19482214</ArticleId></ArticleIdList></Reference><Reference><Citation>Seshasai S.R., Wijesuriya S., Sivakumaran R., Nethercott S., Erqou S., Sattar N. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172:209&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">22231610</ArticleId></ArticleIdList></Reference><Reference><Citation>De Berardis G., Sacco M., Strippoli G.F., Pellegrini F., Graziano G., Tognoni G. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ. 2009;339:b4531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2774388</ArticleId><ArticleId IdType="pubmed">19897665</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowkes F.G., Price J.F., Stewart M.C., Butcher I., Leng G.C., Pell A.C. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA. 2010;303:841&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">20197530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">11519503</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.J., Park D.W., Kim Y.H., Kang S.J., Lee S.W., Lee C.W. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med. 2010;362:1374&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pubmed">20231231</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt D.L., Fox K.A., Hacke W., Berger P.B., Black H.R., Boden W.E. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706&#x2013;1717.</Citation><ArticleIdList><ArticleId IdType="pubmed">16531616</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22608367</PMID><DateCompleted><Year>2012</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1275</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>6</Issue><PubDate><Year>2012</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Atencion primaria</Title><ISOAbbreviation>Aten Primaria</ISOAbbreviation></Journal><ArticleTitle>[Recommendations for breast cancer screening with mammography in the medium risk population: update of PAPPS 2012].</ArticleTitle><Pagination><StartPage>366</StartPage><EndPage>367</EndPage><MedlinePgn>366-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aprim.2012.03.005</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marzo-Castillejo</LastName><ForeName>Merc&#xe8;</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Grupo de C&#xe1;ncer del Programa de Actividades Preventivas y de Promoci&#xf3;n de la Salud (PAPPS), Unitat de Suport a la Recerca de Costa de Ponent-Institut d'Investigaci&#xf3; en Atenci&#xf3; Prim&#xe0;ria (IDIAP) Jordi Gol, Direcci&#xf3; d'Atenci&#xf3; Prim&#xe0;ria Costa de Ponent, Institut Catal&#xe0; de la Salut, Barcelona, Espa&#xf1;a. mmarzoc@gencat.cat</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mel&#xfa;s Palaz&#xf3;n</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Bellas Beceiro</LastName><ForeName>Bego&#xf1;a</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><CollectiveName>Grupo de expertos de c&#xe1;ncer del PAPPS de semFYC</CollectiveName></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList><VernacularTitle>Recomendaciones para el cribado del c&#xe1;ncer de mama con mamograf&#xed;a en poblaci&#xf3;n de riesgo medio. Actualizaci&#xf3;n PAPPS 2012.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2012</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Aten Primaria</MedlineTA><NlmUniqueID>9111075</NlmUniqueID><ISSNLinking>0212-6567</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055088" MajorTopicYN="N">Early Detection of Cancer</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008327" MajorTopicYN="Y">Mammography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22608367</ArticleId><ArticleId IdType="pmc">PMC7025224</ArticleId><ArticleId IdType="doi">10.1016/j.aprim.2012.03.005</ArticleId><ArticleId IdType="pii">S0212-6567(12)00119-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Globocan 2008. Cancer Incidence and Mortality Worldwide in 2008 [consultado 30 Ene 2012]. Disponible en: http://globocan.iarc.fr/</Citation></Reference><Reference><Citation>Marzo Castillejo M, Bellas Beceiro B, Melus Palaz&#xf3;n E, Vela Vallesp&#xed;n C, Nuin Villanueva M, et al. Prevenci&#xf3;n del c&#xe1;ncer [consultado 30 Ene 2012]. Disponible en: http://papps.org/suplemento_ap_09.php</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8171398</ArticleId><ArticleId IdType="pubmed">23399505</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf8;tzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2009;CD001877.</Citation><ArticleIdList><ArticleId IdType="pubmed">19821284</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson H.D., Tyne K., Naik A., Bougatsos B., Chan B.K., Humphrey L. Screening for Breast Cancer: An Update for the U.S, Preventive Services Task Force. Ann Intern Med. 2009;151:727&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2972726</ArticleId><ArticleId IdType="pubmed">19920273</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Task Force on Preventive Health Care, Tonelli M, Gorber SC, Joffres M, Dickinson J, Singh H, Lewin G, et al. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ. 2011;183:1991-2001 [consultado 30 Ene 2012]. Disponible en: http://canadiantaskforce .ca /recommendations/2011 01_eng.html</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3225421</ArticleId><ArticleId IdType="pubmed">22106103</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G.H., Oxman A.D., Vist G., Kunz R., Falck-Ytter Y., Alonso-Coello P., para el GRADE Working Group Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick-Lewis D, Hodgson N, Ciliska D, Peirson P, Gauld M, Liu YY, et al. Breast cancer screening. October 7, 2011 [consultado 6 May 2012]. Disponible en: http://www.canadiantaskforce.ca/docs/breast_cancer_2011_systematic_review_ENG.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>